Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis

被引:58
作者
Oelzner, P [1 ]
Franke, S [1 ]
Müller, A [1 ]
Hein, G [1 ]
Stein, G [1 ]
机构
[1] Univ Jena, Dept Internal Med 4, D-07740 Jena, Germany
关键词
rheumatoid arthritis; osteoporosis; pro-inflammatory cytokines; vitamin D; PTH;
D O I
10.1093/rheumatology/38.9.841
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Regarding interactions between pro-inflammatory cytokines and bone metabolism in rheumatoid arthritis (RA), we investigated the relationship between the serum levels of interleukin (IL)-1 beta, IL-6, soluble interleukin-2 receptor (sIL-2r), C-reactive protein (CRP), the vitamin D metabolites 25-hydroxyvitamin D3 (250HD(3)) and 1,25-dihydroxyvitamin D3 [1,25(OH)(2)D-3], intact parathyroid hormone (iPTH) as well as serum and urinary parameters of bone turnover in 74 post-menopausal women with RA. Results. SIL-2r correlated negatively with 1,25(OH)(2)D-3 (P < 0.01), whereas IL-6 showed a positive correlation with urinary excretion of deoxypyridinoline-collagen cross-links (P < 0.01). 1,25(OH)(2)D-3 (P < 0.01) and iPTH (P < 0.01) were negatively related to CRP, whereas the urinary excretion of pyridinoline (P < 0.01) and deoxypyridinoline (P < 0.01)-collagen cross-links showed a positive correlation with CRP. 1,25(OH)(2)D-3 (P < 0.01) and iPTH (P < 0.05) were positively related to bone alkaline phosphatase as a marker of osteoblast function. Conclusion. Our data indicate that IL-6 is a critical determinant of increased bone resorption in post-menopausal RA women with high disease activity and that serum levels of 1,25(OH)(2)D-3 are inversely related to T-cell activation.
引用
收藏
页码:841 / 847
页数:7
相关论文
共 41 条
[1]  
AMETT FC, 1988, ARTHRITIS RHEUM, V31, P315
[2]  
ASTBURY C, 1994, BRIT J RHEUMATOL, V33, P11
[3]   HUMAN FETAL HEPATOCYTES RESPOND TO INFLAMMATORY MEDIATORS AND EXCRETE BILE [J].
BAUER, J ;
LENGYEL, G ;
THUNG, SN ;
JONAS, U ;
GEROK, W ;
ACS, G .
HEPATOLOGY, 1991, 13 (06) :1131-1141
[4]   The mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines [J].
Bondeson, J .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1997, 29 (02) :127-150
[5]   STRUCTURE-FUNCTION-RELATIONSHIPS IN THE VITAMIN-D ENDOCRINE SYSTEM [J].
BOUILLON, R ;
OKAMURA, WH ;
NORMAN, AW .
ENDOCRINE REVIEWS, 1995, 16 (02) :200-257
[6]   Mononuclear phagocytes and rheumatoid synovitis - Mastermind or workhorse in arthritis? [J].
Burmester, GR ;
Stuhlmuller, B ;
Keyszer, G ;
Kinne, RW .
ARTHRITIS AND RHEUMATISM, 1997, 40 (01) :5-18
[7]   THE ROLE OF VITAMIN-D METABOLITES IN THE TREATMENT OF OSTEOPOROSIS [J].
CIVITELLI, R .
CALCIFIED TISSUE INTERNATIONAL, 1995, 57 (06) :409-414
[8]  
Deodhar AA, 1996, BRIT J RHEUMATOL, V35, P309
[9]   Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis [J].
Fujikawa, Y ;
Sabokbar, A ;
Neale, S ;
Athanasou, NA .
ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (11) :816-822
[10]  
Gough A, 1998, J RHEUMATOL, V25, P1282